WAY DIFFERENTIAL DIAGNOSIS Cervical Dysplasia AND CERVICAL CANCER

• 1. 宫颈癌预后标志微生物及其在制备宫颈癌预后预测诊断产品中的应用 [P] . 中国专利： CN113444803A . 2021-09-28
• 2. 宫颈癌预后相关基因及其在制备宫颈癌预后预测诊断产品中的应用 [P] . 中国专利： CN113444804A . 2021-09-28
• 3. DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CERVICAL DYSPLASIA AND CERVICAL CANCER [P] . 俄罗斯专利： RU2538618C2 . 2015-01-10

  机译： 宫颈异型增生和宫颈癌的鉴别诊断技术

• 4. METHOD FOR DIFFERENTIAL DIAGNOSIS OF CERVICAL INTRAEPITHELIAL NEOPLASIA OF GRADE III AND MICROINVASIVE CERVICAL CANCER ASSOCIATED WITH HUMAN PAPILLOMA VIRUS [P] . 俄罗斯专利： RU0002735660C1 . 2020-11-05

  机译： Ⅲ型宫颈上皮内淋巴瘤与人乳头瘤病毒相关的微侵袭性宫颈癌的鉴别诊断方法

• 5. METHOD FOR DIFFERENTIAL DIAGNOSIS OF CERVICAL NEOPLASIES AND CERVICAL CANCER IN SITU [P] . 俄罗斯专利： RU2019114331A . 2020-11-09

  机译： 原位宫颈癌和宫颈癌的鉴别诊断方法

• 1. Intravoxel incoherent motion magnetic resonance imaging for diagnosis of cervical cancer and evaluation of response of uterine cervical cancer to radiochemotherapy： A pilot study [J] . Yanchun Wang, Shan Hu, Xuemei Hu, 肿瘤学与转化医学（英文） . 2015,第004期
• 2. Intravoxel incoherent motion magnetic resonance imaging for diagnosis of cervical cancer and evaluation of response of uterine cervical cancer to radiochemotherapy：A pilot study [J] . Yanchun Wang, Daoyu Hu, Shan Hu, 中德临床肿瘤学杂志（英文版） . 2015,第004期
• 3. The Use of Artificial Intelligence on Segmental Volumes, Constructed from MRI and CT Images, in the Diagnosis and Staging of Cervical Cancers and Thyroid Cancers: A Study Protocol for a Randomized Controlled Trial [J] . Tudor Florin Ursuleanu, Andreea Roxana Luca, Liliana Gheorghe, 生物医学工程（英文） . 2021,第006期
• 4. The Use of Artificial Intelligence on Colposcopy Images, in the Diagnosis and Staging of Cervical Precancers: A Study Protocol for a Randomized Controlled Trial [J] . Andreea Roxana Luca, Tudor Florin Ursuleanu, Liliana Gheorghe, 生物医学工程（英文） . 2021,第006期
• 5. Chinese guidelines for diagnosis and treatment of cervical cancer 2018 (English version) [J] . 中国癌症研究（英文版） . 2019,第002期
• 6. The impact of a cervical dysplasia diagnosis on individual cancer prevention habits over time: a bicentric case-control study [J] . Rippinger N., Heinzler J., Bruckner T., Archives of gynecology and obstetrics. . 2019,第3期
• 7. Aggregation induced Raman scattering of squaraine dye: Implementation in diagnosis of cervical cancer dysplasia by SERS imaging [J] . Narayanan Nisha, Karunakaran Varsha, Paul Willi, Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices . 2015,第Null期
• 8. Prevention of Cervical Cancer Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia [J] . Hillemanns Peter, Friese Klaus, Dannecker Christian, Geburtshilfe und Frauenheilkunde . 2019,第2期
• 9. Cervical Cancer Screening: The Role of PAP Smear, Hybrid Capture and Visual Inspection in the Diagnosis of Premalignant and Cervical Cancer Lesions [C] . P. Naud, J. Matos, L. Hammcs, International Multidisciplinary Congress . 2003
• 10. Creating a mobile platform for cervical cancer diagnosis. [D] . Saulnier, Nicholas P. 2016
• 11. Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear Cervical Intraepithelial Neoplasia Cervical Cancer and High Risk HPV for Anogenital Dysplasia [O] . Maryam Sadat Hosseini, Donya Khosravi, Farah Farzaneh, 2018
• 12. Cervical dysplasia and cervical cancer in pregnancy: diagnosis and outcome [O] . Kärrberg Cecilia 2012

• 1. Toll样受体-4在宫颈不典型增生与宫颈癌组织中的表达及意义 [C] . 王永军 ,段华 . 中华医学会第十次全国妇产科学术会议 . 2012
• 2. Survivin与Fas在宫颈不典型增生和宫颈癌中的表达及其临床意义 [A] . 杜俊瑶 . 2004